Yifeng Pharmacy: Plans to use up to 300 million yuan of idle raised funds for cash management

robot
Abstract generation in progress

Yifeng Pharmacy announced on March 3rd that on April 15, 2025, the fifth session of the Board of Directors will hold its fifteenth meeting to review and approve the proposal regarding the use of some idle raised funds for entrusted wealth management. The company agrees to use a maximum of up to 300 million yuan (i.e., no more than 300 million yuan) of idle raised funds for cash management. The investment will focus on high-security, highly liquid, principal-protected floating yield RMB structured deposits and other financial products. This authorization is valid for 12 months from the date of board approval, and funds within the limit can be rolled over as needed. This matter will not affect the progress of the raised funds’ investment projects or the company’s normal production and operations.

Daily Economic News

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin